Yayınlar & Eserler

Yayın Ağı
Makaleler 61
Tümü (61)
SCI-E, SSCI, AHCI (46)
SCI-E, SSCI, AHCI, ESCI (51)
ESCI (4)
Scopus (51)
TRDizin (8)
Diğer Yayınlar (1)

1. Dual-Action 3D Bioprinted Scaffolds with MXene Quantum Dots for Tumor Suppression and Breast Tissue Regeneration Postmastectomy

Alkaya D., ÖZGENÇ ÇINAR Ö., CEYLAN A., EKİM O., Aykut G., Regi Saleth L., et al.
Advanced NanoBiomed Research , cilt.5, sa.11, 2025 (ESCI, Scopus) identifier identifier

2. Plasmonic Enhanced Nonlinear Absorption of Tris(2-aminoethyl)amine (TREN) Functional Ag, Pt, and Pd Nanoparticle-GQDs Complexes and Their Evaluation as Potential Bioimaging Applications

ÜNLÜ B. A., Kirit E., Celik D., YILDIZ E., KARATAY A., BOYACIOĞLU B., et al.
ACS Applied Bio Materials , cilt.8, sa.7, ss.6261-6277, 2025 (ESCI, Scopus) identifier identifier

3. Nanotherapeutic Strategies for Overcoming the Blood–Brain Barrier: Applications in Disease Modeling and Drug Delivery

Kirit E., Gökçe C., Altun B., Yilmazer A.
ACS OMEGA , cilt.10, sa.17, ss.1-20, 2025 (SCI-Expanded, Scopus)

4. MXenes as emerging materials to repair electroactive tissues and organs

Alagarsamy K. N., Saleth L. R., Sekaran S., Fusco L., Delogu L. G., Pogorielov M., et al.
Bioactive Materials , cilt.48, ss.583-608, 2025 (SCI-Expanded, Scopus) identifier

5. Cost-Effective and Simple Prototyping PMMA Microfluidic Chip and Open-Source Peristaltic Pump for Small Volume Applications

PANATLI O., Gurcan C., ARI F., ÜNAL M. A., YÜKSEKKAYA M., YILMAZER AKTUNA A.
Micro , cilt.5, sa.2, 2025 (Scopus) identifier identifier

6. Introduction to MXene chemistries in biology, medicine and sensing

Pogorielov M., YILMAZER AKTUNA A., Delogu L. G., Gogotsi Y.
Nanoscale , cilt.17, sa.19, ss.11781-11784, 2025 (SCI-Expanded, Scopus) identifier identifier

7. Delineating the Potential Therapeutic Effects of Lobaric Acid as a Novel Strategy in the Treatment of Melanoma

Jama H. A., Ensoy M., YILMAZER AKTUNA A., CANSARAN DUMAN D.
Current Medicinal Chemistry , cilt.32, sa.14, ss.2792-2808, 2025 (SCI-Expanded, Scopus) identifier identifier

8. Exploring Charge Transfer Mechanisms in Schiff Base-Modified N-Doped GQDs: Insights from DFT and Pump-Probe Spectroscopy for Bioimaging Applications

Hançe S., Erdener D., Öztürk B. I., YILDIZ E., KARATAY A., BOYACIOĞLU B., et al.
ChemistrySelect , cilt.9, sa.41, 2024 (SCI-Expanded, Scopus) identifier

9. Bridging the gap: Advanced biosensor technologies for early-stage oral cancer diagnosis based on biomarker detection

Aksoy Z. B., İL D. B., Celik D., ŞENGÜN D. N., ÜNAL M. A., Kaya S. I., et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY , cilt.180, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

10. Nanoplastics: Immune Impact, Detection, and Internalization after Human Blood Exposure by Single-Cell Mass Cytometry.

Fusco L., Gazzi A., Giro L., Schefer R. B., D'Almeida S. M., Cagliani R., et al.
Advanced materials (Deerfield Beach, Fla.) , sa.2413413, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

11. Biocompatibility of Water-Dispersible Pristine Graphene and Graphene Oxide Using a Close-to-Human Animal Model: A Pilot Study on Swine.

Nicolussi P., Pilo G., Cancedda M. G., Peng G., Chau N. D. Q., De la Cadena A., et al.
Advanced healthcare materials , 2024 (SCI-Expanded, Scopus) identifier identifier

12. Inducing ferroptosis via nanomaterials: a novel and effective route in cancer therapy

Ensoy M., Ozturk B. I., CANSARAN DUMAN D., YILMAZER AKTUNA A.
JPhys Materials , cilt.7, sa.3, 2024 (SCI-Expanded, Scopus) identifier identifier

13. Spatial transcriptomics reveals the interplay between cancer and immune cells directed by MXene quantum dots

CEYLAN A., UYAR R., Çelik D., Rafieerad A., Çinar Ö., Summak G. Y., et al.
Nano Today , cilt.56, 2024 (SCI-Expanded, Scopus) identifier

14. Small Warriors of Nature: Novel Red Emissive Chlorophyllin Carbon Dots Harnessing Fenton-Fueled Ferroptosis for In Vitro and In Vivo Cancer Treatment

Kirbas Cilingir E., Besbinar O., Giro L., Bartoli M., Hueso J. L., Mintz K. J., et al.
SMALL , cilt.20, sa.18, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

15. Biosensors for stem cell-based applications: Current trends and future prospects

Arif T., BİLGE YÜCEL S., UYAR R., ÖZÇELİKAY AKYILDIZ G., Summak G. Y., ÜNAL M. A., et al.
Microchemical Journal , cilt.198, 2024 (SCI-Expanded, Scopus) identifier

16. Early cancer detection based on exosome biosensors in biological samples

UYAR R., ÖZÇELİKAY AKYILDIZ G., Kaya S. İ., BEREKETOĞLU NERGİS S., Beşbinar Ö., ÜNAL M. A., et al.
Sensors and Actuators B: Chemical , cilt.400, 2024 (SCI-Expanded, Scopus) identifier

17. Omic Evaluation of Nanomaterial-Based Photodynamic Therapy of Cancer

Beşbınar Ö. B., UYAR R., YILMAZER AKTUNA A.
Methods in molecular biology (Clifton, N.J.) , cilt.2835, ss.277-288, 2024 (Scopus) identifier identifier

18. Synergized photothermal therapy and magnetic field induced hyperthermia via bismuthene for lung cancer combinatorial treatment.

Yilmazer A., Eroglu Z., Gurcan C., Gazzi A., Ekim O., Sundu B., et al.
Materials today. Bio , cilt.23, ss.100825, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

19. Low Dose of Ti3C2 MXene Quantum Dots Mitigate SARS-CoV-2 Infection

YILMAZER AKTUNA A., Alagarsamy K. N., Gokce C., Summak G. Y., Rafieerad A., Bayrakdar F., et al.
Small Methods , cilt.7, sa.8, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

20. V4C3 MXene Immune Profiling and Modulation of T Cell-Dendritic Cell Function and Interaction

Fusco L., Gazzi A., Shuck C. E., Orecchioni M., Ahmed E. I., Giro L., et al.
Small Methods , cilt.7, sa.8, 2023 (SCI-Expanded, Scopus) identifier identifier

21. Amino-functionalized nitrogen-doped graphene quantum dots and silver-graphene based nanocomposites: Ultrafast charge transfer and a proof-of-concept study for bioimaging applications

KARATAY A., ERDENER ÇIRALI D., Gurcan C., Yildiz E., YILMAZER AKTUNA A., BOYACIOĞLU B., et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY , cilt.426, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

22. 2D Materials for Cardiac Tissue Repair and Regeneration

Gokce C., Gurcan C., Delogu L. G., YILMAZER AKTUNA A.
FRONTIERS IN CARDIOVASCULAR MEDICINE , cilt.9, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

23. Emerging 2D materials for antimicrobial applications in the pre- and post-pandemic era

Gokce C., Gurcan C., Besbinar O., ÜNAL M. A., YILMAZER AKTUNA A.
NANOSCALE , cilt.14, sa.2, ss.239-249, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

24. Graphene oxide activates B cells with upregulation of granzyme B expression: evidence at the single-cell level for its immune-modulatory properties and anticancer activity

Orecchioni M., Fusco L., Mall R., Bordoni V., Fuoco C., Rinchai D., et al.
NANOSCALE , cilt.14, sa.2, ss.333-349, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

25. Facemask Global Challenges: The Case of Effective Synthesis, Utilization, and Environmental Sustainability

Shirvanimoghaddam K., Czech B., Yadav R., Gokce C., Fusco L., Delogu L. G., et al.
SUSTAINABILITY , cilt.14, sa.2, 2022 (SCI-Expanded, SSCI, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

26. Reasons for success and lessons learnt from nanoscale vaccines against COVID-19

Kisby T., YILMAZER AKTUNA A., Kostarelos K.
NATURE NANOTECHNOLOGY , cilt.16, sa.8, ss.843-850, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

27. Lateral dimension and amino-functionalization on the balance to assess the single-cell toxicity of graphene on fifteen immune cell types

Fusco L., Orecchioni M., Reina G., Bordoni V., Fuoco C., Gurcan C., et al.
NANOIMPACT , cilt.23, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

28. 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2

ÜNAL M. A., Bayrakdar F., Fusco L., Besbinar O., Shuck C. E., Yalcin S., et al.
NANO TODAY , cilt.38, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

29. Graphene Oxide Nanosheets Interact and Interfere with SARS-CoV-2 Surface Proteins and Cell Receptors to Inhibit Infectivity

ÜNAL M. A., Bayrakdar F., NAZIR H., Besbinar O., Gurcan C., Lozano N., et al.
SMALL , cilt.17, sa.25, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

30. Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 in vitro

ÜNAL M. A., BİTİRİM C. V., Summak G. Y., BEREKETOĞLU NERGİS S., Zeytin I. C., Besbinar O., et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY , sa.5, ss.449-460, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

31. Biocompatibility studies of macroscopic fibers made from carbon nanotubes: Implications for carbon nanotube macrostructures in biomedical applications

Yan J. S., Orecchioni M., Vitale F., Coco J. A., Duret G., Antonucci S., et al.
CARBON , cilt.173, ss.462-476, 2021 (SCI-Expanded, Scopus) identifier identifier

32. Deep Tissue Translocation of Graphene Oxide Sheets in Human Glioblastoma 3D Spheroids and an Orthotopic Xenograft Model

de Lazaro I., Sharp P., Gurcan C., CEYLAN A., Stylianou M., Kisby T., et al.
ADVANCED THERAPEUTICS , cilt.4, sa.1, 2021 (SCI-Expanded, Scopus) identifier identifier

33. Bioinks for Bioprinting Tissues and Organs

CAN Y., KARACA R., ÖZBEK F., BOZ G., YILMAZER AKTUNA A., HURİ P.
Natural and Applied Sciences Journal , cilt.3, sa.2, ss.13-33, 2020 (TRDizin)

34. Understanding factors affecting human chondrocyte culturing: an experimental study

Kılıç P., Gurcan C., Gürman G., Yılmazer Aktuna A.
CELL AND TISSUE BANKING , cilt.21, sa.4, ss.585-596, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

35. Utility investigation of automated techniques in hematopoietic progenitor cell count and viability assessment in the Good Manufacturing Practice (GMP) setting

Kılıç P., Bay M., Baydın P., Şeker Ş., Coşkun Ö., Ülker O. L., et al.
Experimental Biomedical Research , cilt.3, sa.4, ss.231-238, 2020 (TRDizin) Creative Commons License identifier

36. Utility investigation of automated techniques in hematopoietic progenitor cell count and viability assessment in the Good Manufacturing Practice (GMP) setting

KILIÇ P., Bay M., Yıldırım Y., Baydın P., Şeker Ş., Coşkun Ö., et al.
Experimental Biomedical Research , cilt.3, ss.231-238, 2020 (TRDizin) identifier

37. Graphene, other carbon nanomaterials and the immune system: toward nanoimmunity-by-design

Gazzi A., Fusco L., Orecchioni M., Ferrari S., Franzoni G., Yan J. S., et al.
JOURNAL OF PHYSICS-MATERIALS , cilt.3, sa.3, 2020 (ESCI, Scopus) Sürdürülebilir Kalkınma identifier identifier

38. Bioinspired Scaffold Action Under the Extreme Physiological Conditions of Simulated Space Flights: Osteogenesis Enhancing Under Microgravity

Avitabile E., Fusco L., Minardi S., Orecchioni M., Zavan B., YILMAZER AKTUNA A., et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY , cilt.8, 2020 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

39. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic

Weiss C., Carriere M., Fusco L., Capua I., Regla-Nava J. A., Pasquali M., et al.
ACS NANO , cilt.14, sa.6, ss.6383-6406, 2020 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

40. Stem Cells and Psyche: Perspectives and a Review of the Literature

Kumbasar H., Duman B., Kurt Yüksel M., Civriz Bozdağ S., Kılıç P., Yılmazer Aktuna A., et al.
Journal of oncological sciences , cilt.6, sa.2, ss.103-118, 2020 (TRDizin)

41. Toward High-Dimensional Single-Cell Analysis of Graphene Oxide Biological Impact: Tracking on Immune Cells by Single-Cell Mass Cytometry

Orecchioni M., Bordoni V., Fuoco C., Reina G., Lin H., Zoccheddu M., et al.
SMALL , cilt.16, sa.21, 2020 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

42. Where is human-based cellular pharmaceutical R&D taking us in cartilage regeneration?

Alkaya D., Gurcan C., Kılıç P., Yılmazer Aktuna A., Gürman G.
3 BIOTECH , cilt.10, sa.4, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

43. Photocatalytically Active Graphitic Carbon Nitride as an Effective and Safe 2D Material for In Vitro and In Vivo Photodynamic Therapy

Taheri H., Ünal M. A., Sevim M., Gurcan C., Ekim O., Ceylan A., et al.
SMALL , sa.10, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

44. A closer look at the genotoxicity of graphene based materials

Gurcan C., Taheri H., Bianco A., Delogu L. G., YILMAZER AKTUNA A.
JOURNAL OF PHYSICS-MATERIALS , cilt.3, sa.1, 2020 (ESCI, Scopus) identifier identifier

45. Utility investigation of automated techniques in hematopoietic progenitor cell count and viability assessment in the Good Manufacturing Practice (GMP) setting

KILIÇ P., Bay M., BAYDIN P., Şeker Ş., Coşkun Ö., LALEGÜL Ö., et al.
Experimental Biomedical Research , cilt.3, sa.4, ss.231-238, 2020 (TRDizin)

46. Graphene and other 2D materials: a multidisciplinary analysis to uncover the hidden potential as cancer theranostics

Fusco L., Gazzi A., Peng G., Shin Y., Vranic S., Bedognetti D., et al.
THERANOSTICS , cilt.10, sa.12, ss.5435-5488, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

47. Photodynamic Therapy Based on Graphene and MXene in Cancer Theranostics

Gazzi A., Fusco L., Khan A., Bedognetti D., Zavan B., Vitale F., et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY , cilt.7, 2019 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier

48. A CD34+Cell Enrichment Protocol of Hematopoietic Stem Cells in a Well-Established Quality Management System

Kılıç P., Bay M., Yildirim Y., Coskun Ö., Seker Ş., Baydın P., et al.
CELLS TISSUES ORGANS , cilt.207, sa.1, ss.15-20, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

49. Targeting Mitochondrial Defects to Increase Longevity in Animal Models of Neurodegenerative Diseases

Casajus Pelegay E., Puzzo F., YILMAZER AKTUNA A., Cagin U.
REVIEWS ON BIOMARKER STUDIES OF METABOLIC AND METABOLISM-RELATED DISORDERS , cilt.1134, ss.89-110, 2019 (SCI-Expanded) identifier identifier

50. Reprogramming of Human Melanocytes and Melanoma Cells with Yamanaka Factors

Taheri H., Cagin U., YILMAZER AKTUNA A.
PRE-CLINICAL MODELS , cilt.1916, ss.249-261, 2019 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

51. Tendency of K562 Chronic Myeloid Leukemia Cells Towards Cell Reprogramming

YILMAZER AKTUNA A.
TURKISH JOURNAL OF HEMATOLOGY , cilt.35, sa.4, ss.260-264, 2018 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

52. Evaluation of cancer stemness in breast cancer and glioblastoma spheroids in vitro

YILMAZER AKTUNA A.
3 BIOTECH , cilt.8, sa.9, 2018 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

53. Cellular reprogramming: A new way to understand aging mechanisms

Ilce B. Y., Cagin U., YILMAZER AKTUNA A.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY , cilt.7, sa.2, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

54. Cancer cell lines involving cancer stem cell populations respond to oxidative stress

YILMAZER AKTUNA A.
Biotechnology Reports , cilt.17, ss.24-30, 2018 (Scopus) Sürdürülebilir Kalkınma identifier

55. Reprogramming human melanocytes and melanoma cells with Yamanaka factors

YILMAZER AKTUNA A., TAHERI H.
Hacettepe Journal of Biology and Chemistry , 2018 (TRDizin)

56. Graphene Based Materials in Neural Tissue Regeneration

Aydin T., Gurcan C., Taheri H., YILMAZER AKTUNA A.
CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 3: STEM CELLS, BIO-MATERIALS AND TISSUE ENGINEERING , cilt.1107, ss.129-142, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

57. Kök Hücre Araştırmalarında ve Kliniğe Uyarlanmasında Küresel Standartlar Uluslararası Kök Hücre AraştırmalarıDerneği’nin 2016 Kılavuzu’na Kısa Bakış

TOPAL ÇELİKKAN F., YILMAZER AKTUNA A., Güngör Ordueri N. E., CAN A.
Turkiye Klinikleri J Med Ethics Law Hist-Special Topics , cilt.3, sa.2, ss.61-73, 2017 (Hakemli Dergi)

58. Efficient transduction of melanoma cells with Sendai viral vectors

YILMAZER AKTUNA A., Taheri H., CAN A.
Turk Hijyen ve Deneysel Biyoloji Dergisi , cilt.74, sa.2, ss.113-120, 2017 (Scopus, TRDizin) Sürdürülebilir Kalkınma identifier

59. New surprises from an old favourite: The emergence of telomerase as a key player in the regulation of cancer stemness

Terali K., YILMAZER AKTUNA A.
BIOCHIMIE , cilt.121, ss.170-178, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

60. On the Far Side of Telomeres: The Many Roles of Telomerase in the Acquisition and Retention of Cancer Stemness

Terali K., YILMAZER AKTUNA A.
TELOMERE - A COMPLEX END OF A CHROMOSOME , ss.187-214, 2016 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier

61. Reprogramming cancer cells: A novel approach for cancer therapy or a tool for disease-modeling?

YILMAZER AKTUNA A., de Lazaro I., Taheri H.
CANCER LETTERS , cilt.369, sa.1, ss.1-8, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 35

1. From cancer research to anti-virals: a journey with 2D materials

Yilmazer Aktuna A.
2D Materials 2024, Wenzhou, Çin, 09 Kasım 2024, ss.1, (Özet Bildiri)

2. THERANOSTIC APPROACHES IN ECHINOCOCCOSIS: A NEW PARADIGM FOR DIAGNOSIS AND TREATMENT

TAYLAN ÖZKAN H. A., Beyler B., CANSARAN DUMAN D., YILMAZER AKTUNA A.
11TH NATIONAL AND 4TH INTERNATIONAL CONGRESS OF HYDATIDOLOGY, Türkiye, 02 Ekim 2024, (Tam Metin Bildiri)

3. Unveiling Theranostic Potential: Exosome Camouflage With Cu-Doped Carbon Dots For Glioblastoma Treatment

çelik d., Beşbinar Ö., kirbas çilingir e., UYAR R., YILMAZER AKTUNA A.
2024 IEEE 14 International Conference “Nanomaterials: Applications & Properties” (NAP-2024), Riga, Letonya, 8 - 13 Eylül 2024, (Özet Bildiri)

4. Assessment of MXene Quantum Dot Influence on Tumor Microenvironment Through Spatial Transcriptomics

çelik d., CEYLAN A., Gogotsi Y., Delogu L., Dhingra S., YILMAZER AKTUNA A., et al.
2024 IEEE 14 International Conference “Nanomaterials: Applications & Properties” (NAP-2024), Riga, Letonya, 08 Eylül 2024, (Özet Bildiri)

5. Leveraging Omic Biology for the Advancement of Cancer Nanotherapies

Yilmazer Aktuna A.
2024 IEEE 14th International Conference “Nanomaterials: Applications & Properties”, Riga, Letonya, 08 Eylül 2024, ss.313, (Özet Bildiri)

6. Mxenes to Label and Track Mesenchymal Stem Cells

UYAR R., ÜNAL M. A., YILMAZER AKTUNA A.
MXenes: Changing the World, the 3rd International MXene Conference, Drexel, Amerika Birleşik Devletleri, 7 - 09 Ağustos 2024, (Özet Bildiri)

7. Mo2Ti2C3 MXenes as combinatorial nanoplatforms for cancer therapy

UYAR R., CEYLAN A., YILMAZER AKTUNA A.
MXenes: Changing the World, the 3rd International MXene Conference, Drexel, Amerika Birleşik Devletleri, 5 - 07 Ağustos 2024, (Özet Bildiri)

8. From cancer research to anti-virals: a journey with MXenes and 2D materials

Yilmazer Aktuna A.
3rd International MXene Conference, Pennsylvania, Amerika Birleşik Devletleri, 05 Ağustos 2024, ss.1, (Özet Bildiri)

9. Spatial Transcriptomic Evaluation of The Effect of MXene Quantum Dots On Tumor Microenvironment

UYAR R., YILMAZER AKTUNA A.
24th IEEE International Conference on Nanotechnology, Gijon, İspanya, 8 - 11 Temmuz 2024, (Özet Bildiri)

10. Undelying miRNA profile of Carbon Dot loaded exosome-induced PDT

Beşbinar Ö., UYAR R., YILMAZER AKTUNA A.
24th IEEE International Conference on Nanotechnology, Gijon, İspanya, 8 - 11 Temmuz 2024, (Özet Bildiri)

11. EFFECT OF MXENE NANOSHEETS ON THE DIFFERENTIATION OF SH-SY5Y CELLS INTO MATURE NEURONS

Çelik D., Dhingra S., Yilmazer Aktuna A.
IEEE NANO 2024, Gijon, İspanya, 08 Temmuz 2024, ss.255, (Özet Bildiri)

12. Exploiting omic biology to better understand and improve cancer nanotherapeutics

Yilmazer Aktuna A.
IEEE International Conference on Nanotechnology 2024, Gijon, İspanya, 08 Temmuz 2024, ss.1, (Özet Bildiri)

13. Investigation Of Optical Properties Of 3-Amino-1-Propanol Functionalized N-Doped Graphene Quantum Dots And Metal Nanocomposites

Karatay A., Yıldız M., Yılmazer Aktuna A., Elmalı A.
International Ankara Multidisciplinary Studies Congress, Ankara, Türkiye, 5 - 06 Mart 2024, ss.1022-1023, (Özet Bildiri) Sürdürülebilir Kalkınma

14. From Cancer Research to Antiviral Research: a Journey with 2D Materials

Yılmazer Aktuna A.
IEEE NAP 2023, Bratislava, Slovakya, 10 Eylül 2023, (Özet Bildiri)

15. Schiff Base Decorated Amino-functionalized Nitrogen-Doped Graphene Quantum Dots and Their Silver Nanocomposites: Photophysical Properties and Bioimaging Applications

Hançe S., Erdener Çıralı D., Öztürk İ., Yıldız E., Karatay A., Boyacıoğlu B., et al.
FOTONİK 2023 | Ulusal Optik, Elektro-Optik ve Fotonik Çalıştayı, İstanbul, Türkiye, 08 Eylül 2023, ss.38, (Özet Bildiri) Sürdürülebilir Kalkınma

16. 2DM for Health & Medical Applications

Yılmazer Aktuna A.
Graphene 2023, Manchester, İngiltere, 28 Haziran 2023, (Özet Bildiri)

17. IMMUNE COMPATIBILITY OF 2D BISMUTHENE NANOSHEETS FOR FUTURE COMBINED MAGNETIC HYPERTHERMIA AND PHOTOTHERMAL THERAPY

Giro L., Gurcan C., Eroglu Z., Gazzi A., Ekim O., Sundu B., et al.
Tissue Engineering and Regenerative Medicine International Society (TERMIS), Krakow, Polonya, 28 Haziran - 01 Temmuz 2022, cilt.29, ss.1561-1562, (Özet Bildiri) identifier

18. 2D materials for antimicrobial applications in the pre- and post-pandemic era

YILMAZER AKTUNA A.
American Advanced Materials Fall Congress, Amerika Birleşik Devletleri, 29 Ekim - 05 Kasım 2022, (Özet Bildiri)

19. 2D materials in antiviral research

YILMAZER AKTUNA A.
Graphene Week 2022, Almanya, 5 - 09 Eylül 2022, (Özet Bildiri)

20. Optimizing the Isolation and Culturing Conditions of Human Autologous Chondrocytes

Kılıç P., Gürcan C., Alkaya D., Gürman G., Yılmazer Aktuna A., Malatyalı B., et al.
BIOMED2019, İzmir, Türkiye, 27 - 30 Ekim 2019, (Özet Bildiri)

21. Applications of graphene based materials in biomedical research

YILMAZER AKTUNA A.
BIOMED2019, 17 - 20 Ekim 2019, (Özet Bildiri)

22. Photodynamic therapy with 2D materials

YILMAZER AKTUNA A.
Graphene Week 2019, 21 - 25 Ekim 2019, (Özet Bildiri)

23. Graphene-based nanotechnological approaches for cancer therapy

YILMAZER AKTUNA A.
Uluslarası 6. İlaç Kimyası Kongresi, 22 - 25 Mart 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

24. Graphene Based Nanomaterials for Cancer Therapy

YILMAZER AKTUNA A.
7th International Conference and Exhibition on Cell and Gene Therapy, 15 - 16 Mart 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

25. Uyarılmış Pluripotent Kök Hücreler ve Kullanım Alanları

YILMAZER AKTUNA A.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2018, (Özet Bildiri)

26. The Use of Graphene Based Materials in Cancer Research

YILMAZER AKTUNA A.
1st Workshop NanoBioMed Sardinia 2017, Sassari, İtalya, 24 - 27 Haziran 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

27. Non-Viral Induction Of Transıent Cell Reprogramming In Mouse Skeletal Muscle To Enhance Tissue Regeneration

YILMAZER AKTUNA A., DE LAZARO I., NAM Y., QUBISI S., RAZAK A., MAIZATUL F., et al.
ISSCR 2017, Boston, Amerika Birleşik Devletleri, 14 - 17 Haziran 2017, (Özet Bildiri)

28. Forced Expression Of Reprogramming Factors (OKSM) In Human Melanoma Cells Alters Cancer-Related Pathways And Tumorigenicity

TAHERI H., KUTLU K., YILMAZER AKTUNA A.
ISSCR 2017, Boston, Amerika Birleşik Devletleri, 14 - 17 Haziran 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

29. Treatment of tumor spheroids with graphene oxide

GURCAN C., TAHERI H., DE LAZARO I., KOSTARELOS K., YILMAZER AKTUNA A.
BIOMED, Ankara, Türkiye, 12 - 14 Mayıs 2017, (Özet Bildiri)

30. The effect of cellular reprogramming on the tumorigenicity of melanoma cells

TAHERI H., YILMAZER AKTUNA A.
BIOMED 2017, Ankara, Türkiye, 12 - 14 Mayıs 2017, (Özet Bildiri)

31. Transfection of human melanoma cells with reprogramming factors (OKSM) alters cancer-related pathways and tumorigenicity

YILMAZER AKTUNA A., TAHERI H.
6th International Conference and Exhibition onCell and Gene Therapy, Madrid, İspanya, 27 - 28 Mart 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

32. The current state of the art around the toxicity and genotoxicity of graphene materials

YILMAZER AKTUNA A.
3rd Emerging 2D Materials Graphene Conference from Laboratory to Industry 2016, İstanbul, Türkiye, 20 - 21 Ekim 2016, (Özet Bildiri)

33. In vivo reprogramming to pluripotency enhances regeneration and functional rehabilitation of injured skeletal muscle

de Lazaro I., YILMAZER AKTUNA A., Nam Y., Kostarelos K.
EMBO Conference Cell Therappy today: Achievements, Hope and Hype, Almanya, 9 - 12 Eylül 2015, (Özet Bildiri)

34. Teratoma free in vivo reprogramming to pluripotency in the mouse liver and generation of i2PS cells

de Lazaro I., Bussy C., YILMAZER AKTUNA A., Kostarelos K.
Wellcome Trust Conference. The Biology of Regenerative Medicines, Birleşik Krallık, 22 - 24 Nisan 2015, (Özet Bildiri)

35. The Interaction between Artificially Enveloped Adenovirus and Blood Components

YILMAZER AKTUNA A., Kostarelos K.
European Society of Gene and Cell Therapy (ESGCT) Konferansı 2010, Milan, İtalya, 22 - 25 Ekim 2010, (Tam Metin Bildiri)
Kitaplar 1

1. Sözlük ve Ekler

CAN A., YILMAZER AKTUNA A., TOPAL ÇELİKKAN F., ORDUERİ N. E.
Kök Hücre Araştırma ve Kliniğe Uyarlama Kılavuzu, Prof. Dr. Alp CAN, Editör, ULUSLARARASI KÖK HÜCRE ARAŞTIRMA DERNEĞİ (ISSCR), ss.32-39, 2017
Metrikler

Yayın

108

Yayın (WoS)

53

Yayın (Scopus)

52

Atıf (WoS)

1717

H-İndeks (WoS)

19

Atıf (Scopus)

1904

H-İndeks (Scopus)

19

Atıf (Scholar)

2524

H-İndeks (Scholar)

22

Proje

30

Tez Danışmanlığı

12

Açık Erişim

14
BM Sürdürülebilir Kalkınma Amaçları